Close
Back to PTIE Stock Lookup
Pages: 1 2 »» Last Page

Cassava Sciences (PTIE) – Company Press Releases

Mar 27, 2019 08:30 AM Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.
Mar 27, 2019 08:30 AM Pain Therapeutics Announces Name Change to Cassava Sciences, Inc.
Mar 25, 2019 08:30 AM Pain Therapeutics Reports 2018 Financial Results and Corporate Update
Mar 25, 2019 08:30 AM Pain Therapeutics Reports 2018 Financial Results and Corporate Update
Feb 5, 2019 08:00 AM Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY
Feb 5, 2019 08:00 AM Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY
Jan 17, 2019 09:00 AM Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin
Jan 17, 2019 09:00 AM Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin
Jan 16, 2019 09:00 AM Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health
Jan 16, 2019 09:00 AM Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health
Jan 7, 2019 08:30 AM Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY
Jan 7, 2019 08:30 AM Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY
Dec 18, 2018 06:00 PM Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1
Dec 18, 2018 06:00 PM Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1
Dec 6, 2018 07:30 AM Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease
Dec 6, 2018 07:30 AM Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease
Nov 12, 2018 07:30 AM Pain Therapeutics Appeals FDA Decision on REMOXY
Nov 12, 2018 07:30 AM Pain Therapeutics Appeals FDA Decision on REMOXY
Oct 29, 2018 04:05 PM Pain Therapeutics Reports Third Quarter 2018 Financial Results
Oct 29, 2018 04:05 PM Pain Therapeutics Reports Third Quarter 2018 Financial Results
Oct 23, 2018 07:30 AM Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial Results
Oct 23, 2018 07:30 AM Pain Therapeutics Invites you to Join a Conference Call on Third Quarter 2018 Financial Results
Oct 16, 2018 08:50 AM New Research Coverage Highlights Adesto Technologies, Pain Therapeutics, U.S. Global Investors, GTx, Columbus McKinnon, and Baytex Energy — Consolidated Revenues, Company Growth, and Expectations fo
Oct 11, 2018 07:30 AM Pain Therapeutics Announces Appointment of Chief Financial Officer
Oct 11, 2018 07:30 AM Pain Therapeutics Announces Appointment of Chief Financial Officer
Oct 4, 2018 07:30 AM Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s Disease
Oct 4, 2018 07:30 AM Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s Disease
Oct 2, 2018 07:48 PM Pain Therapeutics Announces Investor Call to Provide Strategic Update
Oct 2, 2018 07:48 PM Pain Therapeutics Announces Investor Call to Provide Strategic Update
Aug 17, 2018 05:15 PM Pain Therapeutics Announces Closing of $11.3 Million Registered Direct Offering
Aug 17, 2018 05:15 PM Pain Therapeutics Announces Closing of $11.3 Million Registered Direct Offering
Aug 16, 2018 07:00 AM Pain Therapeutics Announces $11.3 Million Registered Direct Offering Priced At-the-Market
Aug 16, 2018 07:00 AM Pain Therapeutics Announces $11.3 Million Registered Direct Offering Priced At-the-Market
Aug 15, 2018 08:00 AM Pain Therapeutics Awarded $3.2 Million NIH Grant to Study Alzheimer’s Disease
Aug 6, 2018 09:22 AM DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CII
Aug 6, 2018 07:00 AM Complete Response Letter Issued for REMOXY™
Aug 6, 2018 07:00 AM Complete Response Letter Issued for REMOXY™
Jul 26, 2018 07:00 AM Pain Therapeutics Reports Second Quarter 2018 Financial Results
Jul 26, 2018 07:00 AM Pain Therapeutics Reports Second Quarter 2018 Financial Results
Jun 26, 2018 08:30 PM Results of FDA Advisory Committee Meeting for REMOXY® ER
Jun 26, 2018 05:35 PM Pain Therapeutics Announces Results of FDA Advisory Committee Meeting for REMOXY ER
Jun 26, 2018 05:35 PM Pain Therapeutics Announces Results of FDA Advisory Committee Meeting for REMOXY ER
May 9, 2018 07:00 AM Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY® ER
May 9, 2018 07:00 AM Pain Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update on REMOXY® ER
Mar 20, 2018 08:00 AM DURECT Announces FDA Advisory Committee Meeting for REMOXY® ER
Mar 19, 2018 07:00 AM Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER®
Mar 19, 2018 07:00 AM Pain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY ER®
Mar 1, 2018 08:00 AM FDA Accepts REMOXY® NDA for Review, Sets PDUFA Date of August 7, 2018
Mar 1, 2018 08:00 AM FDA Accepts REMOXY® NDA for Review, Sets PDUFA Date of August 7, 2018
Feb 14, 2018 08:00 AM DURECT Announces Resubmission of REMOXY® ER New Drug Application by its licensee, Pain Therapeutics
Pages: 1 2 »» Last Page

Back to PTIE Stock Lookup